Torthaí cuardaigh - Shu‐Ping Wang
- 1 - 9 toradh as 9 á dtaispeáint
-
1
The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape de réir Lan-Hsin Wang, Marvin Angelo Esteban Aberin, Sean M. Wu, Shu‐Ping Wang
Foilsithe / Cruthaithe 2021Revisão -
2
FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage... de réir Shu-Ping Wang, Shiqi Wu, Shihui Huang, Yi-Xuan Tang, Liu-Qiong Meng, Feng Liu, Qihua Zhu, Yungen Xu
Foilsithe / Cruthaithe 2021Artigo -
3
Traditional Chinese medicine against COVID-19: Role of the gut microbiota de réir Zhihua Yang, Yangxi Liu, Lin Wang, Shanshan Lin, Xiangdong Dai, Haifeng Yan, Zhao Ge, Qiuan Ren, Hui Wang, Feng Zhu, Shu‐Ping Wang
Foilsithe / Cruthaithe 2022Revisão -
4
A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription de réir Shu‐Ping Wang, Zhanyun Tang, Chun–Wei Chen, Miho Shimada, Richard P. Koche, Lan-Hsin Wang, Tomoyoshi Nakadai, Alan Chramiec, Andrei V. Krivtsov, Scott A. Armstrong, Robert G. Roeder
Foilsithe / Cruthaithe 2017Artigo -
5
Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy de réir Chia-Sing Lu, Ching‐Wen Lin, Ya‐Hsuan Chang, Hsuan‐Yu Chen, Wei-Chia Chung, Wei‐Yun Lai, Chao‐Chi Ho, Tong‐Hong Wang, Chi‐Yuan Chen, Chen-Lin Yeh, Sean M. Wu, Shu‐Ping Wang, Pan‐Chyr Yang
Foilsithe / Cruthaithe 2020Artigo -
6
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis de réir Ching-Wen Lin, Lu-Kai Wang, Shu‐Ping Wang, Yih‐Leong Chang, Yi-Ying Wu, Hsuan‐Yu Chen, Tzu-Hung Hsiao, Wei‐Yun Lai, Hsuan‐Hsuan Lu, Ya-Hsuan Chang, Shuenn-Chen Yang, Ming‐Wei Lin, Chi‐Yuan Chen, Tse‐Ming Hong, Pan‐Chyr Yang
Foilsithe / Cruthaithe 2016Artigo -
7
Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF de réir Yi Zhang, Younghoon Jang, Ji‐Eun Lee, Jae‐Woo Ahn, Longxia Xu, Michael R. Holden, Evan M. Cornett, Krzysztof Krajewski, Brianna J. Klein, Shu‐Ping Wang, Yali Dou, Robert G. Roeder, Brian D. Strahl, Scott B. Rothbart, Xiaobing Shi, Kai Ge, Tatiana G. Kutateladze
Foilsithe / Cruthaithe 2019Artigo -
8
Impaired cell fate through gain-of-function mutations in a chromatin reader de réir Liling Wan, Shasha Chong, Xuan Fan, Angela Liang, Xiaodong Cui, Leah Gates, Thomas S. Carroll, Yuanyuan Li, Lijuan Feng, Guochao Chen, Shu‐Ping Wang, Michael V. Ortiz, Sara K. Daley, Xiaolu Wang, Hongwen Xuan, Alex Kentsis, Tom W. Muir, Robert G. Roeder, Haitao Li, Wei Li, Robert Tjian, Hong Wen, C. David Allis
Foilsithe / Cruthaithe 2019Artigo -
9
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets de réir Leah Gates, Guowei Gu, Yue Chen, Aarti D. Rohira, Jonathan T. Lei, Ross A. Hamilton, Yang Yu, David M. Lonard, Jin Wang, Shu‐Ping Wang, David G. Edwards, Philip F. Lavere, Jiangyong Shao, Ping Yi, Antrix Jain, Sung Yun Jung, Anna Malovannaya, Shunqiang Li, Jieya Shao, Robert G. Roeder, Matthew J. Ellis, Jun Qin, Suzanne A.W. Fuqua, Bert W. O’Malley, Charles E. Foulds
Foilsithe / Cruthaithe 2018Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Gene
Genetics
Cancer
Cancer research
Cell biology
Histone
Transcription factor
Acetylation
Biochemistry
Breast cancer
Chemistry
Chromatin
DNA
Enhancer
Immunology
Internal medicine
Medicine
Alternative medicine
Cancer cell
Carboplatin
Cell
Cell cycle
Cell fate determination
Cell function
Chemotherapy
Cisplatin
Coactivator
Computational biology
Coronavirus